Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.

Pattacini P, Nitrosi A, Giorgi Rossi P, Iotti V, Ginocchi V, Ravaioli S, Vacondio R, Braglia L, Cavuto S, Campari C; RETomo Working Group.

Radiology. 2018 Aug;288(2):375-385. doi: 10.1148/radiol.2018172119. Epub 2018 Jun 5.

PMID:
29869961
2.

Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study.

Vicentini M, Ballotari P, Giorgi Rossi P, Venturelli F, Sacchettini C, Greci M, Mangone L, Pezzarossi A, Manicardi V.

Diabetes Res Clin Pract. 2018 May 26. pii: S0168-8227(17)32037-5. doi: 10.1016/j.diabres.2018.04.036. [Epub ahead of print] Review.

PMID:
29807100
3.

Cohort profile: the Italian Network of Longitudinal Metropolitan Studies (IN-LiMeS), a multicentre cohort for socioeconomic inequalities in health monitoring.

Caranci N, Di Girolamo C, Giorgi Rossi P, Spadea T, Pacelli B, Broccoli S, Ballotari P, Costa G, Zengarini N, Agabiti N, Bargagli AM, Cacciani L, Canova C, Cestari L, Biggeri A, Grisotto L, Terni G, Costanzo G, Mirisola C, Petrelli A; IN-LiMeS Group.

BMJ Open. 2018 Apr 20;8(4):e020572. doi: 10.1136/bmjopen-2017-020572.

4.

Effectiveness of integrated care model for type 2 diabetes: A population-based study in Reggio Emilia (Italy).

Ballotari P, Venturelli F, Manicardi V, Ferrari F, Vicentini M, Greci M, Pignatti F, Storani S, Giorgi Rossi P.

PLoS One. 2018 Mar 27;13(3):e0194784. doi: 10.1371/journal.pone.0194784. eCollection 2018.

5.

Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.

Del Mistro A, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Girlando S, Rizzolo R, Frayle H, Trevisan M, Sani C, Burroni E, Giorgi Rossi P, Cuzick J, Ronco G; New Technologies for Cervical CancerWorking Group.

Int J Cancer. 2018 Jul 15;143(2):333-342. doi: 10.1002/ijc.31326. Epub 2018 Mar 9.

PMID:
29453769
6.

[Experimenting an instrument for cancer screening programming in Italy].

Sinopoli A, Saulle R, Guarino A, Cereda D, Giorgi Rossi P, Serantoni G, Giordano L, De Belvis AG, Marino M, Bellentani D, Federici A, La Torre G.

Ig Sanita Pubbl. 2017 Jul-Aug;73(4):303-309. Italian.

PMID:
29099822
7.

The effects of improving the mesothelioma surveillance network on sensitivity, timeliness in reporting and asbestos exposure assessment.

Mangone L, Di Felice E, Storchi C, Romanelli A, Broccoli S, Vicentini M, Giorgi Rossi P.

Med Lav. 2017 Oct 27;108(5):367-76. doi: 10.23749/mdl.v108i5.5929.

PMID:
29084128
8.

Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy.

Ballotari P, Vicentini M, Manicardi V, Gallo M, Chiatamone Ranieri S, Greci M, Giorgi Rossi P.

BMC Cancer. 2017 Oct 25;17(1):703. doi: 10.1186/s12885-017-3696-4.

9.

[Cervical and breast cancer screening among immigrant women resident in Italy].

Francovich L, Di Napoli A, Giorgi Rossi P, Gargiulo L, Giordani B, Petrelli A.

Epidemiol Prev. 2017 May-Aug;41(3-4 (Suppl 1)):18-25. doi: 10.19191/EP17.3-4S1.P018.061. Italian.

10.

Role of HPV DNA testing in modern gynaecological practice.

Ronco G, Giorgi Rossi P.

Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:107-118. doi: 10.1016/j.bpobgyn.2017.08.002. Epub 2017 Aug 12. Review.

PMID:
28918099
11.

Factors Influencing the Accuracy of Infectious Disease Reporting in Migrants: A Scoping Review.

Giorgi Rossi P, Riccardo F, Pezzarossi A, Ballotari P, Dente MG, Napoli C, Chiarenza A, Velasco Munoz C, Noori T, Declich S.

Int J Environ Res Public Health. 2017 Jul 5;14(7). pii: E720. doi: 10.3390/ijerph14070720. Review.

12.

[Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].

Di Stefano F, Giorgi Rossi P, Carozzi F, Ronco G, Cacciani L, Vecchi S, Naldoni C, Segnan N; Gruppo di lavoro MIDDIR – HPV test in primary screening.

Epidemiol Prev. 2017 Mar-Apr;41(2):116-124. doi: 10.19191/EP17.2.P116.031. Italian.

PMID:
28627153
13.

Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.

Giorgi Rossi P, Carrozzi G, Federici A, Mancuso P, Sampaolo L, Zappa M.

J Med Screen. 2018 Mar;25(1):17-23. doi: 10.1177/0969141317704476. Epub 2017 Jun 14.

PMID:
28614991
14.

Lifestyle-tailored interventions for South Asians with type 2 diabetes living in high-income countries: a systematic review.

Ballotari P, Ferrari F, Ballini L, Chiarenza A, Manicardi V, Giorgi Rossi P.

Acta Diabetol. 2017 Aug;54(8):785-794. doi: 10.1007/s00592-017-1008-8. Epub 2017 Jun 6. Review.

PMID:
28585044
15.

Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa).

Bernardi D, Belli P, Benelli E, Brancato B, Bucchi L, Calabrese M, Carbonaro LA, Caumo F, Cavallo-Marincola B, Clauser P, Fedato C, Frigerio A, Galli V, Giordano L, Giorgi Rossi P, Golinelli P, Morrone D, Mariscotti G, Martincich L, Montemezzi S, Naldoni C, Paduos A, Panizza P, Pediconi F, Querci F, Rizzo A, Saguatti G, Tagliafico A, Trimboli RM, Zappa M, Zuiani C, Sardanelli F.

Radiol Med. 2017 Oct;122(10):723-730. doi: 10.1007/s11547-017-0769-z. Epub 2017 May 25.

16.

Survey on Urinary Levels of Aflatoxins in Professionally Exposed Workers.

Ferri F, Brera C, De Santis B, Fedrizzi G, Bacci T, Bedogni L, Capanni S, Collini G, Crespi E, Debegnach F, Ferdenzi P, Gargano A, Gattei D, Luberto F, Magnani I, Magnani MG, Mancuso P, Menotta S, Mozzanica S, Olmi M, Ombrini G, Sala O, Soricelli S, Vicentini M, Giorgi Rossi P.

Toxins (Basel). 2017 Mar 24;9(4). pii: E117. doi: 10.3390/toxins9040117.

17.

Indicators for monitoring screening programs with primary HPV test.

Zorzi M, Giorgi Rossi P; Gruppo di lavoro GISCI sugli Indicatori dello screening con test HPV primario.

Epidemiol Prev. 2017 Jan-Feb;41(1):1-32. doi: 10.19191/EP17.1S1.P001.001. English, Italian.

PMID:
28322534
18.

Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy.

Ballotari P, Venturelli F, Greci M, Giorgi Rossi P, Manicardi V.

Int J Endocrinol. 2017;2017:6039356. doi: 10.1155/2017/6039356. Epub 2017 Feb 20.

19.

Changes in mortality and incidence of prostate cancer by risk class in different periods in Italy: the possible effects of PSA spread.

Vicentini M, Sacchettini C, Trama A, Nicolai N, Gatta G, Botta L, Valdagni R, Giorgi Rossi P; Prostate Cancer High-Resolution Study Working Group.

Tumori. 2017 May 12;103(3):292-298. doi: 10.5301/tj.5000613. Epub 2017 Feb 28.

PMID:
28291906
20.

Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature.

Del Mistro A, Frayle H, Rizzi M, Fantin G, Ferro A, Angeletti PM, Giorgi Rossi P, Altobelli E.

PLoS One. 2017 Mar 6;12(3):e0172226. doi: 10.1371/journal.pone.0172226. eCollection 2017.

21.

Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy.

Giorgi Rossi P, Carretta E, Mangone L, Baracco S, Serraino D, Zorzi M; Colorectal Cancer Screening IMPATTO Working Group*.

J Med Screen. 2018 Mar;25(1):32-39. doi: 10.1177/0969141316686391. Epub 2017 Feb 14.

PMID:
28195508
22.

Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy.

Lupato V, Holzinger D, Höfler D, Menegaldo A, Giorgi Rossi P, Del Mistro A, Da Mosto MC, Pawlita M, Boscolo-Rizzo P.

PLoS One. 2017 Jan 19;12(1):e0170091. doi: 10.1371/journal.pone.0170091. eCollection 2017.

23.

Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.

Giorgi Rossi P, Bisanzi S, Allia E, Mongia A, Carozzi F, Gillio-Tos A, De Marco L, Ronco G, Gustinucci D, Del Mistro A, Frayle H, Iossa A, Fantacci G, Pompeo G, Cesarini E, Bulletti S, Passamonti B, Rizzi M, Penon MG, Barca A, Benevolo M.

J Clin Microbiol. 2017 Apr;55(4):1056-1065. doi: 10.1128/JCM.01794-16. Epub 2017 Jan 18.

24.

Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round.

Del Mistro A, Frayle H, Ferro A, Fantin G, Altobelli E, Giorgi Rossi P.

Prev Med Rep. 2016 Dec 23;5:166-168. doi: 10.1016/j.pmedr.2016.12.017. eCollection 2017 Mar.

25.

Trends in net survival from kidney cancer in six European Latin countries: results from the SUDCAN population-based study.

Mangone L, Bossard N, Marcos-Gragera R, Pezzarossi A, Roncaglia F, Giorgi Rossi P; GRELL EUROCARE-5 Working Group.

Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S121-S127. doi: 10.1097/CEJ.0000000000000297.

PMID:
28005615
26.

Comment on "Incidence of Type 1 Diabetes among Children and Adolescents in Italy between 2009 and 2013: The Role of a Regional Childhood Diabetes Registry".

Ballotari P, Manicardi V, Giorgi Rossi P.

J Diabetes Res. 2016;2016:6302508. Epub 2016 Nov 22. No abstract available.

27.

Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.

Benevolo M, Allia E, Gustinucci D, Rollo F, Bulletti S, Cesarini E, Passamonti B, Giovagnoli MR, Carico E, Carozzi FM, Mongia A, Fantacci G, Confortini M, Rubino T, Fodero C, Prandi S, Marchi N, Farruggio A, Coccia A, Macrì L, Ghiringhello B, Ronco G, Bragantini E, Polla E, Maccallini V, Negri G, Giorgi Rossi P; New Technologies for Cervical Cancer Screening 2 (NTCC2) Working Group.

Cancer Cytopathol. 2017 Mar;125(3):212-220. doi: 10.1002/cncy.21800. Epub 2016 Dec 7.

28.

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.

Giorgi Rossi P, Carozzi F, Federici A, Ronco G, Zappa M, Franceschi S; Italian Screening in HPV vaccinated girls Consensus Conference group.

Prev Med. 2017 May;98:21-30. doi: 10.1016/j.ypmed.2016.11.020. Epub 2016 Nov 25.

29.

Cognitive Clusters in Specific Learning Disorder.

Poletti M, Carretta E, Bonvicini L, Giorgi-Rossi P.

J Learn Disabil. 2018 Jan/Feb;51(1):32-42. doi: 10.1177/0022219416678407. Epub 2016 Nov 17.

PMID:
27856603
30.

Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.

Ronco G, Zappa M, Franceschi S, Tunesi S, Caprioglio A, Confortini M, Del Mistro A, Carozzi F, Segnan N, Zorzi M, Giorgi-Rossi P; Italian HPV Survey Working Group.

Eur J Cancer. 2016 Nov;68:148-155. doi: 10.1016/j.ejca.2016.09.008. Epub 2016 Oct 15.

31.

Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy.

Passamonti B, Gustinucci D, Giorgi Rossi P, Cesarini E, Bulletti S, Carlani A, Martinelli N, Broccolini M, D'Angelo V, D'Amico MR, Di Dato E, Galeazzi P, Malaspina M, Spita N, Tintori B, Giaimo MD.

J Med Screen. 2017 Sep;24(3):153-162. doi: 10.1177/0969141316663580. Epub 2016 Sep 10.

PMID:
27614992
32.

Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators.

Placidi A, Capparucci P, Di Luzio A, Manca G, Mania E, Filippini T, Giorgi Rossi P.

Acta Cytol. 2016;60(5):458-464. Epub 2016 Aug 10.

PMID:
27504992
33.

Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program.

Maggino T, Sciarrone R, Murer B, Dei Rossi MR, Fedato C, Maran M, Lorio M, Soldà M, Zago F, Giorgi Rossi P, Zorzi M.

Br J Cancer. 2016 Aug 23;115(5):525-32. doi: 10.1038/bjc.2016.216. Epub 2016 Aug 4.

34.

Prevalence of Primary HPV in Djibouti: Feasibility of Screening for Early Diagnosis of Squamous Intraepithelial Lesions.

Petrelli A, Di Napoli A, Giorgi Rossi P, Rossi A, Luccini D, Di Marco I, Traoré AL, Gillio Tos A, Trevisan M, Mirisola C, Costanzo G.

J Low Genit Tract Dis. 2016 Oct;20(4):321-6. doi: 10.1097/LGT.0000000000000240.

PMID:
27467824
35.

Differences in mortality by immigrant status in Italy. Results of the Italian Network of Longitudinal Metropolitan Studies.

Pacelli B, Zengarini N, Broccoli S, Caranci N, Spadea T, Di Girolamo C, Cacciani L, Petrelli A, Ballotari P, Cestari L, Grisotto L, Giorgi Rossi P; IN-LiMeS Group.

Eur J Epidemiol. 2016 Jul;31(7):691-701. doi: 10.1007/s10654-016-0177-z. Epub 2016 Jul 26.

PMID:
27461270
36.

[The accuracy of the causes of death and the estimated trend: the case of cervix uteri].

Mancuso P, Sacchettini C, Vicentini M, Caroli S, Giorgi Rossi P.

Epidemiol Prev. 2016 Mar-Apr;40(3-4):157-63. doi: 10.19191/EP16.3-4.AD02.076. Italian.

37.

GISCi: an opportunity for more consideration and visibility for young researchers.

Carozzi FM, Giorgi Rossi P, Matucci M, Iossa A, Del Mistro A, Maina G, Venturino E, Taddei GL, Giaimo MD.

Epidemiol Prev. 2016 May-Aug;40(3-4):150. doi: 10.19191/EP16.3-4.AD01.075. No abstract available.

38.

Long-term mortality patterns in a residential cohort exposed to inorganic selenium in drinking water.

Vinceti M, Ballotari P, Steinmaus C, Malagoli C, Luberto F, Malavolti M, Giorgi Rossi P.

Environ Res. 2016 Oct;150:348-56. doi: 10.1016/j.envres.2016.06.009. Epub 2016 Jun 24.

PMID:
27344266
39.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

40.

[Identification, early diagnosis, and monitoring of workers exposed to asbestos. Where are we?].

Merler E, Paci E, Consonni D, Giorgi Rossi P.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):3-6. doi: 10.19191/EP16.1S1.P003.022. Italian. No abstract available.

41.

Diagnostic values of glycated haemoglobin and diagnosis of diabetes: Results of a cross-sectional survey among general practitioners in the province of Reggio Emilia, Italy.

Ballotari P, Roncaglia F, Chiatamone Ranieri S, Greci M, Manicardi V, Giorgi Rossi P.

J Clin Transl Endocrinol. 2016 Jan 13;3:21-25. doi: 10.1016/j.jcte.2016.01.001. eCollection 2016 Mar.

42.

Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.

Gustinucci D, Giorgi Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A, D'angelo V, D'amico MR, Di Dato E, Galeazzi P, Malaspina M, Martinelli N, Spita N, Tintori B, Giaimo MD, Passamonti B.

Am J Clin Pathol. 2016 Jan;145(1):35-45. doi: 10.1093/ajcp/aqv019.

PMID:
26712869
43.

Motivational Interviewing to Treat Overweight Children: 24-Month Follow-Up of a Randomized Controlled Trial.

Broccoli S, Davoli AM, Bonvicini L, Fabbri A, Ferrari E, Montagna G, Panza C, Pinotti M, Storani S, Tamelli M, Candela S, Bellocchio E, Giorgi Rossi P.

Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-1979. Epub 2015 Dec 23.

44.

Letter to the editor: Responding to a call for action--where are we now?

Riccardo F, Giorgi Rossi P, Chiarenza A, Noori T, Declich S.

Euro Surveill. 2015;20(50). doi: 10.2807/1560-7917.ES.2015.20.50.30096. No abstract available.

45.

Recommendation without experts? Epistemological implications in the development of screening guidelines.

Giorgi Rossi P.

Prev Med. 2016 Feb;83:22-5. doi: 10.1016/j.ypmed.2015.11.025. Epub 2015 Dec 7.

PMID:
26674993
46.

[Motivational interviewing to treat overweight children and their parents in paediatrician's medical office: good results, but one year is not sufficient].

Gruppo di lavoro Bambini Molto In Forma (MInF), AUSL Reggio Emilia, Broccoli S, Davoli AM, Albertini P, Bonvicini L, Fabbri A, Ferrari E, Ferrari F, Montagna G, Panza C, Storani S, Candela S, Bellocchio E, Giorgi Rossi P.

Epidemiol Prev. 2015 Sep-Dec;39(5-6):393. Italian. No abstract available.

47.

Impact of the Introduction of Digital Mammography in an Organized Screening Program on the Recall and Detection Rate.

Campari C, Giorgi Rossi P, Mori CA, Ravaioli S, Nitrosi A, Vacondio R, Mancuso P, Cattani A, Pattacini P.

J Digit Imaging. 2016 Apr;29(2):235-42. doi: 10.1007/s10278-015-9843-z.

48.

[Evaluation of the cancer co-pay fee exemption data source (048 code) to estimate cancer incidence].

Mangone L, Rashid I, Vicentini M, Bonelli LA, Borciani E, Casella C, Castaing M, Cirilli C, Di Felice E, Marchesi C, Michiara M, Sciacca S, Seghini P, Sgargi P, Giorgi Rossi P.

Epidemiol Prev. 2015 Jul-Aug;39(4):226-33. Italian.

PMID:
26499235
49.

[HPV vaccination in males: a lost chance for technicians and decision-makers].

Giorgi Rossi P, Giamba C.

Epidemiol Prev. 2015 Jul-Aug;39(4):213-5. Italian. No abstract available.

PMID:
26499230
50.

Screening for colorectal cancer in Italy: 2011-2012 survey.

Zorzi M, Mangone L, Sassatelli R, Baracco S, Budroni M, Castaing M, Cirilli C, Cusimano R, Fusco M, Giacomin A, Giorgi Rossi P, Naldoni C, Pannozzo F, Piffer S, Puppo A, Tisano F, Zappa M; IMPATTO COLONRETTO working group.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):115-25.

Supplemental Content

Loading ...
Support Center